About RDT
Rapid Dose Therapeutics, RDT, is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes.
Formed because of a recognized need to move drug delivery to a new level. RDT provides product innovation, production, and consultation to the pharmaceutical and healthcare manufacturing industry.
RDT’s Mission
Board of Directors
Mark Upsdell
CEO
Mark leads RDT – Rapid Dose Therapeutics, with a unique combination of global business and technology transformational growth experience. Mark’s ability to build high-performance growth oriented teams, including his strategically-selected executive management staff, has served as a growth catalyst to drive revenue results. Mark believes in innovation, strategy and people.
Prior to RDT, Mark was Senior Global Manager of Strategy and Planning at Cisco, and held director positions within Cisco and Hewlett Packard.
Jason Lewis
SVP Business Development
Jason is an entrepreneurial executive with 28+ years of hands-on expertise in growing successful businesses within the healthcare marketing, sales productivity, and software development sectors. His experience is focused in pharmaceutical product launches, marketing, and consultation. Jason builds and manages high performance sales, marketing, and channel teams, develops creative business go-to-market strategies in high growth, mid and late stage venture backed and publicly traded companies.
A results-driven marketing leader, known for innovation and a unique mix of strategic, creative, operational and technical abilities — Jason’s dedication to ensuring success for brands is unwavering.
Previous to RDT, Jason was founder of PharmaComm and RemoteRep® in Ontario, Canada, Director of International Marketing Apotex, and VP of Marketforce a subsidiary of GSW.
Peter Thilo Hasler
Independent Director
Peter Thilo Hasler is the founder and financial analyst of Sphene Capital, a bank-independent research house specializing in the analysis of undervalued small and mid-cap companies, both listed and private. Hasler has a comprehensive knowledge of business analysis and company valuation and was responsible for numerous IPO transactions. Since the foundation of sphaia advisory GmbH in 2015, Hasler offers corporate finance, listing, and communications advice to European SMEs too.
Peter Thilo Hasler is CEFA analyst and member of the board of the German Association for Financial Analysis and Asset Management (DVFA). In addition, Hasler is lecturer at the DVFA and at several private universities, where he teaches company valuation and capital markets theory. Hasler is author of numerous articles and books on business valuation as well as corporate bonds and writes regular columns in the financial press.
Team Members
Mark Upsdell
CEO
Mark leads RDT – Rapid Dose Therapeutics, with a unique combination of global business and technology transformational growth experience. Mark’s ability to build high-performance growth oriented teams, including his strategically-selected executive management staff, has served as a growth catalyst to drive revenue results. Mark believes in innovation, strategy and people.
Prior to RDT, Mark was Senior Global Manager of Strategy and Planning at Cisco, and held director positions within Cisco and Hewlett Packard.
Jason Lewis
SVP Business Development
Jason is an entrepreneurial executive with 28+ years of hands-on expertise in growing successful businesses within the healthcare marketing, sales productivity, and software development sectors. His experience is focused in pharmaceutical product launches, marketing, and consultation. Jason builds and manages high performance sales, marketing, and channel teams, develops creative business go-to-market strategies in high growth, mid and late stage venture backed and publicly traded companies.
A results-driven marketing leader, known for innovation and a unique mix of strategic, creative, operational and technical abilities — Jason’s dedication to ensuring success for brands is unwavering.
Previous to RDT, Jason was founder of PharmaComm and RemoteRep® in Ontario, Canada, Director of International Marketing Apotex, and VP of Marketforce a subsidiary of GSW.
Doug Hyland, CA, CPA
Manager, Systems & Processes
Doug is a highly respected corporate strategist and chartered accountant, focusing on assisting owners of privately held businesses with their business transition process. Doug’s expertise in the areas of taxation, finance and management provide corporations assists company management with transformative strategies intended to build business value. Doug has a wealth of experience in Canada and the United States and he has acted on international assignments for both Canadian and US clients seeking to expand their business investments within their industry.
His diverse strategic financial and business experience spans across multiple industries including manufacturing and distribution, financial services, technology, non-profit, and the health industry. Doug is a renowned thought leader, keynote speaker and recognized contributor of articles outlining the unique challenges of business transition and business wealth transfer techniques both while operating the business and upon exit.
In addition to RDT, Doug is currently acting as Director and Treasurer for OTEC (Ontario Tourism and Hospitality Industry). Prior to RDT, Doug was Director and VP Finance for the Mississauga Board of Trade, Elizabeth Fry Society. Doug is also the founding partner of Lemoine Hyland Chartered Accountants LLP, located in Mississauga, Ontario.